Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis
- PMID: 37650971
- DOI: 10.1007/s00330-023-10160-x
Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis
Abstract
Objectives: The prognostic value of ground-glass opacity at preoperative chest CT scans in early-stage lung adenocarcinomas is a matter of debate. We aimed to clarify the existing evidence through a single-center, retrospective cohort study and to quantitatively summarize the body of literature by conducting a meta-analysis.
Methods: In a retrospective cohort study, patients with clinical stage I lung adenocarcinoma were identified, and the prognostic value of ground-glass opacity was analyzed using multivariable Cox regression. Commercial artificial intelligence software was adopted as the second reader for the presence of ground-glass opacity. The primary end points were freedom from recurrence (FFR) and lung cancer-specific survival (LCSS). In a meta-analysis, we systematically searched Embase and OVID-MEDLINE up to December 30, 2021, for the studies based on the eighth-edition staging system. The pooled hazard ratios (HRs) of solid nodules (i.e., absence of ground-glass opacity) for various end points were calculated with a multi-level random effects model.
Results: In a cohort of 612 patients, solid nodules were associated with worse outcomes for FFR (adjusted HR, 1.98; 95% CI: 1.17-3.51; p = 0.01) and LCSS (adjusted HR, 1.937; 95% CI: 1.002-4.065; p = 0.049). The artificial intelligence assessment and multiple sensitivity analyses revealed consistent results. The meta-analysis included 13 studies with 12,080 patients. The pooled HR of solid nodules was 2.13 (95% CI: 1.69-2.67; I2 = 30.4%) for overall survival, 2.45 (95% CI: 1.52-3.95; I2 = 0.0%) for FFR, and 2.50 (95% CI: 1.28-4.91; I2 = 30.6%) for recurrence-free survival.
Conclusions: The absence of ground-glass opacity in early-stage lung adenocarcinomas is associated with worse postoperative survival.
Clinical relevance statement: Early-stage lung adenocarcinomas manifesting as solid nodules at preoperative chest CT, which indicates the absence of ground-glass opacity, were associated with poor postoperative survival. There is room for improvement of the clinical T categorization in the next edition staging system.
Key points: • In a retrospective study of 612 patients with stage I lung adenocarcinoma, solid nodules were associated with shorter freedom from recurrence (adjusted hazard ratio [HR], 1.98; p = 0.01) and lung cancer-specific survival (adjusted HR, 1.937; p = 0.049). • Artificial intelligence-assessed solid nodules also showed worse prognosis (adjusted HR for freedom from recurrence, 1.94 [p = 0.01]; adjusted HR for lung cancer-specific survival, 1.93 [p = 0.04]). • In meta-analyses, the solid nodules were associated with shorter freedom from recurrence (HR, 2.45) and shorter overall survival (HR, 2.13).
Keywords: Artificial intelligence; Lung neoplasms; Meta-analysis; Multidetector computed tomography; Prognosis.
© 2023. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity.Eur Radiol. 2025 Apr;35(4):2256-2264. doi: 10.1007/s00330-024-11048-0. Epub 2024 Sep 16. Eur Radiol. 2025. PMID: 39285027
-
Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component.J Thorac Oncol. 2020 Apr;15(4):580-588. doi: 10.1016/j.jtho.2019.12.110. Epub 2019 Dec 24. J Thorac Oncol. 2020. PMID: 31877384
-
Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.J Thorac Cardiovasc Surg. 2024 Sep;168(3):685-696.e2. doi: 10.1016/j.jtcvs.2023.11.025. Epub 2023 Nov 22. J Thorac Cardiovasc Surg. 2024. PMID: 37995863
-
Development and validation of a risk prediction model for invasiveness of pure ground-glass nodules based on a systematic review and meta-analysis.BMC Med Imaging. 2024 Jun 17;24(1):149. doi: 10.1186/s12880-024-01313-5. BMC Med Imaging. 2024. PMID: 38886695 Free PMC article.
-
Successful Application of Artificial Intelligence-Assisted Analysis of Invasive Pulmonary Adenocarcinoma Less Than 6 mm in Size: A Case Report and Literature Review.Clin Respir J. 2025 May;19(5):e70073. doi: 10.1111/crj.70073. Clin Respir J. 2025. PMID: 40432547 Free PMC article. Review.
Cited by
-
[Value of CT Quantitative Parameters in Prediction of Pathological Types of Lung Ground Glass Nodules].Zhongguo Fei Ai Za Zhi. 2024 Feb 20;27(2):118-125. doi: 10.3779/j.issn.1009-3419.2024.102.09. Zhongguo Fei Ai Za Zhi. 2024. PMID: 38453443 Free PMC article. Chinese.
-
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.Cancers (Basel). 2025 Mar 4;17(5):882. doi: 10.3390/cancers17050882. Cancers (Basel). 2025. PMID: 40075729 Free PMC article. Review.
-
Radiographical consolidation tumor size and preoperative clinical characteristics are significantly correlated with the postoperative survival of patients with part-solid and pure-solid adenocarcinomas: a propensity score-matched analysis.Surg Today. 2025 May;55(5):607-617. doi: 10.1007/s00595-024-02939-2. Epub 2024 Sep 21. Surg Today. 2025. PMID: 39306602
-
Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.Respir Res. 2024 Feb 21;25(1):96. doi: 10.1186/s12931-024-02727-z. Respir Res. 2024. PMID: 38383329 Free PMC article.
References
-
- Hattori A, Takamochi K, Oh S, Suzuki K (2019) New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer. Jpn J Clin Oncol 49:3–11
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical